Avai Bio AVAI
OTC AVAI
$0.11 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Avai Bio (AVAI) Gross Margin (2019 - 2020)

Avai Bio's (AVAI) quarterly Gross Margin came in at 223.67% in Q4 2020, up 807.55% quarter-over-quarter from 24.65% in Q3 2020.

Analysis

Avai Bio (AVAI) Gross Margin (2019 - 2020) Analysis & Trends

Avai Bio has disclosed Gross Margin across 2 years of filings, most recently posting 223.67% for Q4 2020.

  • In Q4 2020, Gross Margin changed N/A year-over-year to 223.67%; the TTM figure through Dec 2020 stood at 16.83% (down 8317.0% YoY), while the FY2023 annual figure was 14.64%, changed N/A from the prior year.
  • Gross Margin came in at 223.67% for Q4 2020 at Avai Bio, up from 24.65% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 223.67% in Q4 2020 to a low of 36.87% in Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Baidu 4.12 Bn -18.28 Bn 1.76 Mn 0.04%
2 Life360 3.37 Bn 3.10 Bn 126.90 Mn 79.83%
3 Soundhound Ai 2.70 Bn 2.50 Bn 27.93 Mn 45.12%
4 C3.ai 1.47 Bn 895.72 Mn 11.32 Mn 21.94%
5 Spectral Capital 455.65 Mn 450.34 Mn 3.28 Mn 1.03%
6 Spire Global 431.21 Mn 339.54 Mn 6.16 Mn 34.12%
7 Global AI 147.15 Mn 147.11 Mn 82,446.00 71.24%
8 Veritone 83.10 Mn 70.68 Mn 15.46 Mn 63.70%
9 Agassi Sports Entertainment 81.18 Mn 81.11 Mn - -
10 Avai Bio 15.58 Mn 15.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 223.67%
Sep 30, 2020 24.65%
Jun 30, 2020 28.28%
Mar 31, 2020 -36.87%
Jun 30, 2019 100.00%